David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$602M |
| 2 |
Booking.com
BKNG
|
+$582M |
| 3 |
Walmart Inc
WMT
|
+$407M |
| 4 |
Visa
V
|
+$395M |
| 5 |
Johnson & Johnson
JNJ
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$483M |
| 2 |
Salesforce
CRM
|
+$380M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$364M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$336M |
| 5 |
Colgate-Palmolive
CL
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.49% |
| 2 | Consumer Discretionary | 9.18% |
| 3 | Healthcare | 8.57% |
| 4 | Financials | 8% |
| 5 | Industrials | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Global Net Lease
GNL
$2.14B
| $550K | ﹤0.01% |
+42,790
| New | +$588K |
|
3377
Stoke Therapeutics
STOK
$2.16B
| $550K | ﹤0.01% |
65,969
-2,866
| -4% | -$25.9K |
|
3378
DT Midstream
DTM
$12.9B
| $549K | ﹤0.01% |
11,129
+1,444
| +15% | +$74.8K |
|
3379
Phibro Animal Health
PAHC
$1.43B
| $549K | ﹤0.01% |
35,856
-13,806
| -28% | -$211K |
|
3380
CALL
Crown Castle
CCI
$32.5B
| $549K | ﹤0.01% |
4,100
-58,700
| -93% | -$8.11M |
|
|
NGMS
3381
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $548K | ﹤0.01% |
36,020
-30,287
| -46% | -$426K |
|
3382
NorthWestern Energy
NWE
$4.36B
| $547K | ﹤0.01% |
+9,449
| New | +$540K |
|
3383
eGain
EGAN
$198M
| $541K | ﹤0.01% |
71,213
+6,165
| +9% | +$53K |
|
3384
CALL
DHT Holdings
DHT
$3.09B
| $541K | ﹤0.01% |
50,000
| – | – |
|
|
PINC
3385
DELISTED
Premier
PINC
| $539K | ﹤0.01% |
16,639
-188,135
| -92% | -$6.16M |
|
3386
Radian Group
RDN
$4.87B
| $538K | ﹤0.01% |
24,332
-57,246
| -70% | -$1.22M |
|
3387
Ducommun
DCO
$2.74B
| $535K | ﹤0.01% |
9,784
-4,580
| -32% | -$250K |
|
|
BLU
3388
DELISTED
BELLUS Health Inc.
BLU
| $529K | ﹤0.01% |
73,421
-361,892
| -83% | -$2.81M |
|
|
SLGC
3389
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $528K | ﹤0.01% |
207,107
-184,334
| -47% | -$528K |
|
3390
RenaissanceRe
RNR
$13.7B
| $528K | ﹤0.01% |
2,634
-1,201
| -31% | -$242K |
|
|
PTRA
3391
DELISTED
Proterra Inc. Common Stock
PTRA
| $527K | ﹤0.01% |
346,570
+316,280
| +1,044% | +$1.19M |
|
|
CTOS.WS
3392
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
| $527K | ﹤0.01% |
1,645,754
+375,000
| +30% | +$177K |
|
3393
Vivid Seats
SEAT
$81.9M
| $525K | ﹤0.01% |
3,440
-649
| -16% | -$101K |
|
3394
Nurix Therapeutics
NRIX
$2.8B
| $524K | ﹤0.01% |
59,037
-32,672
| -36% | -$340K |
|
3395
CALL
Apollo Global Management
APO
$78.6B
| $524K | ﹤0.01% |
8,300
-109,900
| -93% | -$7.36M |
|
|
TMHC
3396
DELISTED
Taylor Morrison
TMHC
| $524K | ﹤0.01% |
13,700
-9,075
| -40% | -$319K |
|
3397
McGrath RentCorp
MGRC
$2.8B
| $524K | ﹤0.01% |
5,613
-7,411
| -57% | -$733K |
|
3398
CorMedix
CRMD
$667M
| $523K | ﹤0.01% |
126,309
-18,527
| -13% | -$75.8K |
|
|
IAUX
3399
i-80 Gold Corp
IAUX
$1.66B
| $520K | ﹤0.01% |
213,600
-550,000
| -72% | -$1.37M |
|
3400
Starwood Property Trust
STWD
$5.97B
| $518K | ﹤0.01% |
29,283
-45,094
| -61% | -$871K |
|
Similar funds
David Shaw's Q1 2023 Portfolio in Review
As of Q1 2023, David Shaw held 5,246 positions worth $93.4B, up 3.2% from $90.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $9.17B in Q1 2023, closing 860 positions and reducing 1,787 holdings. Its most notable exit was SVB Financial Group, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in State Street Utilities Select Sector SPDR ETF worth $99.9M.
- David Shaw's largest Q1 2023 buy was State Street Utilities Select Sector SPDR ETF: 2,950,552 shares worth $99.9M.
- David Shaw added most to Charles Schwab in Q1 2023, an estimated $602M increase.
- David Shaw's biggest Q1 2023 reduction was Microsoft, cutting an estimated $483M.
- David Shaw fully exited SVB Financial Group in Q1 2023, selling an estimated $163M.
- David Shaw's ten largest holdings make up 11% of its $93.4B portfolio in Q1 2023.
- David Shaw opened 431 new positions and closed 860 in Q1 2023.
- David Shaw's portfolio value rose 3.2% quarter-over-quarter to $93.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.